Early Convalescent Plasma for High-Risk Outpatients with Covid-19

The early administration of convalescent plasma from blood donors who recovered from #COVID19 did not prevent disease progression in acutely ill, high-risk COVID19 patients, according to a new multicenter study that includes work by BAHM President Kevin Schulman: https://www.nejm.org/doi/full/10.1056/NEJMoa2103784?query=featured_home